Towards full control over protein glycosylation: in-vitro glycoengineering of 
influenza A virus hemagglutinin and SARS-CoV-2 spike protein

Juárez-Osorio, Mariana; Darr, Annabell; Volckmar, J.; Bruder, Dunja; Rexer, Thomas; Reichl, Udo

Local TagsRelease HistoryDetailsSummary

Towards full control over protein glycosylation: in-vitro glycoengineering of influenza A virus hemagglutinin and SARS-CoV-2 spike protein

Juárez-Osorio, M., Darr, A., Volckmar, J., Bruder, D., Rexer, T., & Reichl, U. (2023). Towards full control over protein glycosylation: in-vitro glycoengineering of influenza A virus hemagglutinin and SARS-CoV-2 spike protein. Poster presented at GlycoBioTec 2023, Berlin, Germany.

Item is Released

show all hide all

Basic

show hide

Item Permalink: https://hdl.handle.net/21.11116/0000-000E-F56E-3 Version Permalink: https://hdl.handle.net/21.11116/0000-000F-3098-F

Genre: Poster

Files

show Files

Locators

show

Creators

show

hide

Creators:
Juárez-Osorio, Mariana¹, Author
Darr, Annabell¹, Author
Volckmar, J.², Author
Bruder, Dunja^{2, 3}, Author
Rexer, Thomas¹, Author
Reichl, Udo^{1, 2}, Author

Affiliations:
1Bioprocess Engineering, Max Planck Institute for Dynamics of Complex Technical Systems, Max Planck Society, ou_1738140
2Otto-von-Guericke-Universität Magdeburg, External Organizations, ou_1738156
3Immune Regulation Group, Helmholtz Centre for Infection Research, Braunschweig, Germany, ou_persistent22

Content

show

Details

show

hide

Language(s): eng - English

Dates: Created: 2023

Publication Status: Not specified

Pages: -

Publishing info: -

Table of Contents: -

Rev. Type: -

Identifiers: -

Degree: -

Event

show

hide

Title: GlycoBioTec 2023

Place of Event: Berlin, Germany

Start-/End Date: 2023-01-16 - 2023-01-19

Legal Case

show

Project information

show

Source

show